Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Eliem Therapeutics Inc
(NQ:
ELYM
)
6.120
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eliem Therapeutics Inc
< Previous
1
2
3
4
Next >
Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 04, 2023
Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
October 28, 2022
Upgrades
Via
Benzinga
Eliem Therapeutics Outlines Interim Data From Early-Stage Depressive Study
October 05, 2022
Via
Benzinga
Eliem Therapeutics: Q2 Earnings Insights
August 15, 2022
Eliem Therapeutics (NASDAQ:ELYM) reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
September 23, 2022
Gainers
Via
Benzinga
Eliem Therapeutics Shares Fall On Lower Back Pain Trial Setback
August 02, 2022
Via
Benzinga
SVB Leerink Maintains Outperform Rating for Eliem Therapeutics: Here's What You Need To Know
August 16, 2022
SVB Leerink has decided to maintain its Outperform rating of Eliem Therapeutics (NASDAQ:ELYM) and lower its price target from $9.00 to $4.00. Shares of Eliem Therapeutics are trading down 2.08% over...
Via
Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 02, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 02, 2022
Via
Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
July 18, 2022
Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...
Via
Benzinga
Eliem Announces Updated Development Plans For Its Delayed Depression Candidate
July 18, 2022
In April, Eliem Therapeutics Inc (NASDAQ: ELYM) delayed ETX-155 into Phase 2a depression trials to determine the root cause of a lower-than-expected exposure observed in a Phase 1b study in...
Via
Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
July 25, 2022
Gainers
Via
Benzinga
SVB Leerink Maintains Outperform Rating for Eliem Therapeutics: Here's What You Need To Know
July 11, 2022
SVB Leerink has decided to maintain its Outperform rating of Eliem Therapeutics (NASDAQ:ELYM) and lower its price target from $13.00 to $9.00. Shares of Eliem Therapeutics are trading down 4.04% over...
Via
Benzinga
The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives
June 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Eliem Concludes Patient Enrolment In Mid-Stage Study Of Radicular Back Pain Drug
June 27, 2022
Eliem Therapeutics (NASDAQ: ELYM) has completed dosing of the last patient in its Phase 2a trial of ETX-810 in patients with chronic lumbosacral radicular pain (LSRP).
Via
Benzinga
5 Short Squeeze Candidates To Watch This Week: Revlon Tops The List, A SPAC Shifts To Second And More
June 21, 2022
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 16, 2022
Via
Benzinga
93 Biggest Movers From Yesterday
June 14, 2022
Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in...
Via
Benzinga
5 Short Squeeze Candidates To Watch This Week: TherapeuticsMD Tops List While This Arts And Crafts Retailer Joins The Leaderboard
June 13, 2022
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 01, 2022
Via
Benzinga
Mid-Afternoon Market Update: Dow Jumps 300 Points; Crude Oil Rises Over 3%
May 16, 2022
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 300 points on Monday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 16, 2022
Via
Benzinga
73 Biggest Movers From Yesterday
May 17, 2022
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.
Via
Benzinga
Short Squeeze Stocks: VTNR, VERU and 3 Others Experts Think Are Ready to Pop
May 16, 2022
Short squeeze stocks are once again in focus this week as the bears continue to run wild in the stock market.
Via
InvestorPlace
Mid-Day Market Update: Dow Edges Higher; Data Storage Shares Surge
May 16, 2022
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 20 points on Monday.
Via
Benzinga
41 Stocks Moving In Monday's Mid-Day Session
May 16, 2022
Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results.
Via
Benzinga
5 Short Squeeze Candidates To Watch This Week: Vertex Energy Tops List, Medavail Holdings And Camping World Remain Elevated
May 16, 2022
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower; Dow Drops 70 Points
May 16, 2022
U.S. stocks traded lower this morning, with the Nasdaq Composite adding more than 400 points on Friday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2022
April 26, 2022
Upgrades According to Susquehanna, the prior rating for Boyd Gaming Corp (NYSE:BYD) was changed from Neutral to Positive. At the moment, the stock has a 52-week-high of $72.72 and a 52-week-low of...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
April 26, 2022
HC Wainwright & Co. raised Nkarta, Inc. (NASDAQ: NKTX) price target from $25 to $36. Nkarta shares fell 7.2% to $17.38 in pre-market trading.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.